MedinGlobal

Edit Template

CYCLOPHIL ME 50ME

In Stock

CYCLOPHIL ME 50ME contains Ciclosporin 50mg and is listed as a prescription immunosuppressant marketed by Biocon. It belongs to the calcineurin inhibitor class and may be prescribed for the prevention of rejection following selected organ transplants. Its active ingredient suppresses T-cell activation and immune responses. Treatment requires specialist supervision, with monitoring of blood drug levels, kidney function, blood pressure and potential drug interactions.

Medinglobal provides medicine information and enquiry coordination. It does not manufacture, sell or dispense medicines directly. Availability and any subsequent supply are subject to verification by an appropriately authorised independent provider and applicable regulations.

CYCLOPHIL ME 50ME – Composition, Uses and Medicine Enquiries

Product Overview

CYCLOPHIL ME 50ME is listed as a prescription product containing Ciclosporin 50mg, marketed in the source catalogue by Biocon.

It belongs to the immunosuppressant; calcineurin inhibitor class and may be prescribed for the prevention of rejection following selected organ transplants.

Its active ingredient suppresses T-cell activation and immune responses.

Treatment suitability depends on the confirmed diagnosis, previous treatment, organ function and other medicines. The benefit-risk balance, approved use and monitoring plan must be determined by the treating specialist.

Blood drug levels, kidney function, blood pressure and drug interactions require monitoring.

Composition and Strength

Active Ingredient Strength
Ciclosporin 50mg

Product Name: CYCLOPHIL ME 50ME

Generic Name: Ciclosporin

Brand Name: CYCLOPHIL ME 50ME

Strength: 50mg

Listed Marketer: Biocon

The composition and strength should be verified against the original manufacturer-labelled packaging before publication or any medicine enquiry.

Therapeutic Category and Indication

CYCLOPHIL ME 50ME belongs to the immunosuppressant category and is classified as a calcineurin inhibitor.

It may be prescribed for the prevention of rejection following selected organ transplants.

Ciclosporin suppresses T-cell activation and immune responses.

Treatment choice depends on the confirmed diagnosis, previous treatment, organ function and other medicines. The benefit-risk balance, approved use and monitoring plan must be determined by the treating specialist.

Blood drug levels, kidney function, blood pressure and drug interactions require monitoring.

Administration Information

The supplied product information identifies an oral microemulsion formulation taken at consistent times, following the food instructions on the product label.

Administration should follow the treating clinician’s instructions and the approved product label.

Patients should not independently adjust the dose, skip safety monitoring or switch formulations without medical advice.

The exact formulation and administration schedule must be verified against the approved product information.

Product Presentation and Availability

The product enquiry can be made using the following details:

  • Product Name: CYCLOPHIL ME 50ME
  • Generic Name: Ciclosporin
  • Strength: 50mg
  • Company Name: Biocon
  • Therapeutic Category: Immunosuppressant
  • Medicine Class: Calcineurin Inhibitor
  • Indication: Prevention of rejection following selected organ transplants
  • Administration: Oral microemulsion formulation

The exact dosage form, pack size, batch, storage, expiry and product-specific presentation require verification from original manufacturer packaging and an authorised provider.

Product details and supply eligibility may vary by country. A product listing does not confirm current stock or availability.

Prescription and Patient Safety

CYCLOPHIL ME 50ME is listed as a prescription immunosuppressant and requires specialist supervision.

Treatment suitability, contraindications, interactions and monitoring requirements must be evaluated by the treating specialist.

Blood drug levels, kidney function and blood pressure require monitoring. Potential drug interactions must also be assessed.

Patients should follow the approved product label and their treating clinician’s instructions. They should not independently change the treatment schedule or switch formulations.

Medicine Enquiry Coordination Through Medinglobal

Medinglobal is a healthcare coordination platform. It can receive medicine information requests and, where legally permissible, connect patients or institutions with appropriately authorised independent pharmaceutical providers.

Medinglobal does not itself sell, dispense, manufacture or export medicines.

Product availability, lawful supply, prescription validation, commercial terms and destination requirements must be verified by the independent provider. Submitting an enquiry does not guarantee fulfilment.

How to Submit a CYCLOPHIL ME 50ME Enquiry

To help identify the requested product, include the following details:

  1. Product name: CYCLOPHIL ME 50ME.
  2. Generic name: Ciclosporin.
  3. Required strength: 50mg.
  4. Required formulation and quantity.
  5. Destination country.
  6. Valid prescription or institutional documents, where required.

Medinglobal may coordinate an introduction to a suitably authorised provider. The provider independently verifies product details, regulatory eligibility and any transaction.

Frequently Asked Questions

What is CYCLOPHIL ME 50ME used for?

CYCLOPHIL ME 50ME is associated with the prevention of rejection following selected organ transplants. The treating prescriber confirms the approved use.

What is the composition of CYCLOPHIL ME 50ME?

The supplied catalogue lists Ciclosporin 50mg as its active ingredient. The composition should be verified against the original product packaging.

How is CYCLOPHIL ME 50ME administered?

The supplied information identifies an oral microemulsion formulation taken at consistent times, following the food instructions on the label.

Which company is listed for CYCLOPHIL ME 50ME?

Biocon is listed as the marketer in the supplied product information.

Does CYCLOPHIL ME 50ME require medical supervision?

Yes. Blood drug levels, kidney function, blood pressure and potential drug interactions require monitoring.

Can Medinglobal supply CYCLOPHIL ME 50ME directly?

No. Medinglobal coordinates medicine enquiries with independent authorised providers where legally permissible.

Product Name

Generic Name

Brand Name

Composition

Strength

Therapeutic Category

Medicine Class

Indication

Dosage Form

Route of Administration

Reviews

There are no reviews yet.

Be the first to review “CYCLOPHIL ME 50ME”

Your email address will not be published. Required fields are marked *

Pharmaceutical Disclaimer

Medinglobal Platform does not sell, dispense, manufacture or prescribe medicines. Pharmaceutical information on this page is provided solely for general information, product identification and enquiry coordination. Product listing is not medical advice, a recommendation or an offer for sale by Teji Radiance or the Medinglobal Partnership Firm. Prescription medicines require a valid prescription where applicable. Any regulated pharmaceutical activity is undertaken by the relevant independent provider subject to applicable law. Always consult an appropriately qualified healthcare professional before using or changing any medicine.

Scroll to Top